Improvement in glycemic control by gastric electrical stimulation (TANTALUS™) in overweight subjects with type 2 diabetes

Surgical Endoscopy

Volumn 23, Issue 9, 2009, Pages 1955-1960

  Bohdjalian, A ^a   Ludvik, B ^a   Guerci, B ^b   Bresler, L ^b   Renard, E ^c   Nocca, D ^c   Karnieli, E ^d   Assalia, A ^d   Prager, R ^e   Prager, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ctr Hospitalier Univ de Nancy   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d RAMBAM MEDICAL CENTER   (Israel)

^e HIETZING HOSPITAL   (Austria)

Author keywords

Gastric contractility modulation; Gastric pacemaker; Gastric stimulation; Glycemic control; Laparoscopy; Obese diabetes; Weight loss

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; ELECTROSTIMULATION; FEASIBILITY STUDY; FEMALE; GASTRIC ELECTRICAL STIMULATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPLANT; LAPAROSCOPY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BLOOD; BLOOD PRESSURE; ELECTRODE; ELECTROSTIMULATION THERAPY; GASTROINTESTINAL MOTILITY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; SENSORY NERVE; STOMACH ANTRUM;

AFFERENT PATHWAYS; BLOOD PRESSURE; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL MOTILITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LAPAROSCOPY; MALE; OBESITY; PROSPECTIVE STUDIES; PYLORIC ANTRUM; WAIST CIRCUMFERENCE;

EID: 73349102204     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-008-0222-4     Document Type: Article

References (28)

1. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM (2004) The evolving diabetes burden in the United States. Ann Intern Med 140:945-950
2. Kopelman PG, Hitman GA (1998) Diabetes: exploding type II. Lancet 352(Suppl. 4):5
3. Cernea S, Kidron M, Wohlgelernter J, Modi P, Raz I (2005) Dose-response relationship of oral insulin spray in healthy subjects. Diabetes Care 28:1353-1357
4. Inzucchi SE, McGuire DK (2008) New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond. Circulation 117:574-584
5. Ferchak CV, Meneghini LF (2004) Obesity, bariatric surgery and type 2 diabetes-a systematic review. Diabetes Metab Res Rev 20:438-445
6. Moo TA, Rubino F (2008) Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2: 153-158
7. Peles S, Petersen J, Aviv R, Policker S, Abu-Hatoum O, Ben- Haim SA, Gutterman DD, Sengupta JN (2003) Enhancement of antral contractions and vagal afferent signaling with synchronized electrical stimulation. Am J Physiol Gastrointest Liver Physiol 285:G577-G585
8. Rocca AS, Brubaker PL (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140:1687-1694
9. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ (2006) Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol 101:2848-2856
10. Druce M, Bloom SR (2003) Central regulators of food intake. Curr Opin Clin Nutr Metab Care 6:361-367
11. Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, Riener R, Zacherl J, Ludvik B (2006) One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg 5:627-634
12. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026-1031
13. Neeley WE (1972) Simply automated determination of serum or plasma glucose by a hexokinase/glucose-6-phosphate dehydrogenase method. Clin Chem 18:509-515
14. Dunn PJ, Cole RA, Soeldner JS (1979) Further development and automation of a high pressure liquid chromatography method for the determination of glycosylated hemoglobins. Metabolism 28:777-779
15. Yin J, Chen JD (2008) Implantable gastric electrical stimulation: ready for prime time? Gastroenterology 134:665-667
16. De Vries J, De Jongste MJ, Spincemaille G, Staal MJ (2007) Spinal cord stimulation for ischemic heart disease and peripheral vascular disease. Adv Tech Stand Neurosurg 32:63-89
17. Green AL, Wang S, Bittar RG, Owen SL, Paterson DJ, Stein JF, Bain PG, Shlugman D, Aziz TZ (2007) Deep brain stimulation: a new treatment for hypertension? J Clin Neurosci 14:592-595
18. North RB, Roark GL (1995) Spinal cord stimulation for chronic pain. Neurosurg Clin N Am 6:145-155
19. Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC, Mika Y, Rousso B, Burkhoff D, Ben-Haim S, Sabbah HN (2007) Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol 21: 2120-2128 (Pubitemid 46771049)
20. Dockray GJ (2003) The Brain-Gut Axis. In: Yamada T (ed) Basic Mechanisms of Normal and Abnormal Gastrointestinal Function, 4th edn. Lippincott Williams & Wilkins, PA, pp 77-91
21. Cigaina V, Hirschberg AL (2003) Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 11:1456-1462
22. Sobocki J, Thor PJ, Uson J, Diaz-Guemes I, Lipinski M, Calles C, Pascual S (2001) Microchip vagal pacing reduces food intake and body mass. Hepatogastroenterology 48:1783-1787
23. Shikora SA (2004) "What are the Yanks doing?" The U.S. experience with implantable gastric stimulation (IGS) for the treatment of obesity-update on the ongoing clinical trials. Obes Surg Suppl 1:S40-S48
24. Rocca AS, Brubaker PL (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140:1687-1694
25. Andrews PL, Sanger GJ (2002) Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 6:650-656
26. Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128:175-191
27. Liu S, Lei Y, Chen JD (2006) Inhibitory effects and mechanisms of colonic electric stimulation on gastric and rectal tone in conscious dogs. Dis Colon Rectum 49:1749-1754
28. Sanmiguel CP, Haddad W, Aviv R, Cunneen SA, Phillips EH, Kapella W, Soffer EE (2007) The TANTALUS trade mark system for obesity: effect on gastric emptying of solids and ghrelin plasma levels. Obes Surg 17:1503-1509